About Oxford MEStar
Oxford MEStar is a company based in Oxford (United Kingdom) founded in 2013 by Zhanfeng Cui. Oxford MEStar has raised $929.86 thousand across 2 funding rounds. The company has 8 employees as of November 30, 2021. Oxford MEStar operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Oxford, United Kingdom
- Employees 8 as on 30 Nov, 2021
- Founders Zhanfeng Cui
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oxford Mestar Limited
- Date of Incorporation 28 Oct, 2013
- Jurisdiction THAME, OXFORDSHIRE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$929.86 K (USD)
in 2 rounds
-
Latest Funding Round
$523.63 K (USD), Seed
Aug 30, 2016
-
Investors
Not available
-
Employee Count
8
as on Nov 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oxford MEStar
Oxford MEStar has successfully raised a total of $929.86K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $523.63 thousand completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Oxford MEStar
Investment portfolio details for Oxford MEStar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oxford MEStar
Detailed financials for Oxford MEStar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oxford Mestar Comparisons
Peer comparison for Oxford MEStar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oxford MEStar
Oxford MEStar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Oxford MEStar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxford Mestar
Complete news archive for Oxford MEStar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford MEStar
Oxford MEStar was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Oxford MEStar is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Robert Wang is the current CEO of Oxford MEStar.
Oxford MEStar is a funded company, having raised a total of $929.86K across 2 funding rounds to date.
As of Nov 30, 2021, the latest employee count at Oxford MEStar is 8.
Developer of novel scaffolds for tissue engineering and stem cell delivery. The company has developed regenerative medicine and biomaterial products that help in drug delivery and formulation. It provides solutions for stem cell isolation, purification, culture, storage, and formulation under GMP for clinical applications. The company also develops in-vitro diagnostic tools that measure bowel health for the detection of invisible traces of blood in the stool and also offer PetAssist service for animal post-cancer treatment.
Oxford MEStar's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.